Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
This product may appear in research-focused product references under related names
10.1007/s00125-012-2582-5
Developed by Eli Lilly under the code LY3298176, it was approved by the FDA in 2022 (marketed as Mounjaro) and has become one of the most extensively studied incretin-based compounds in current metabolic research
Russian cosmonauts undergo lower body negative pressure (LBNP) sessions to prevent cardiovascular adaptations during LDSF during the final 21 days of missions
US$ 20.09
US$ 22.53
US$ 27.82
US$ 29.93
US$ 24.21
US$ 28.97
US$ 25.72
US$ 25.04
